Market Access
![drugs](/sites/default/files/styles/x_large/public/2023-12/drugs.jpg?itok=MOuvlmAp)
NICE and orphan drug recommendations: Should we be more worr...
Leela Barham uses the very latest data – running up to November 2023 – to take stock of NICE’s Single Technology Appraisal (STA) recommendations on orphan drugs versus non-orphans.